Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study.

Por Amélie Cariou, Roman Rouzier, Sandrine Baffert, Anne-Laure Soilly, Delphine Hequet
Publicado em 2018-01-01

Chlamydomonas reinhardtii Chloroplasts Contain a Homodimeric Pyruvate:Ferredoxin Oxidoreductase That Functions with FDX1(1)([W])([OA])

Por van Lis, Robert, Baffert, Carole, Couté, Yohann, Nitschke, Wolfgang, Atteia, Ariane
Publicado em 2013

Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators

Por Héquet, Delphine, Huchon, Cyrille, Baffert, Sandrine, Alran, Séverine, Reyal, Fabien, Nguyen, Thuy, Combes, Alix, Trichot, Caroline, Alves, Karine, Berseneff, Hélène, Rouzier, Roman
Publicado no Br J Cancer (2017)

Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membra...

Por Inai, Tetsuichiro, Mancuso, Michael, Hashizume, Hiroya, Baffert, Fabienne, Haskell, Amy, Baluk, Peter, Hu-Lowe, Dana D., Shalinsky, David R., Thurston, Gavin, Yancopoulos, George D., McDonald, Donald M.
Publicado em 2004

The patient-breast cancer care pathway: how could it be optimized?

Por Baffert, Sandrine, Hoang, Huong Ly, Brédart, Anne, Asselain, Bernard, Alran, Séverine, Berseneff, Hélène, Huchon, Cyrille, Trichot, Caroline, Combes, Aline, Alves, Karine, Koskas, Martin, Nguyen, Thuy, Roulot, Aurélie, Rouzier, Roman, Héquet, Delphine
Publicado no BMC Cancer (2015)

O(2) reduction and O(2)-induced damage at the active site of FeFe hydrogenase

Por Kubas, Adam, Orain, Christophe, De Sancho, David, Saujet, Laure, Sensi, Matteo, Gauquelin, Charles, Meynial-Salles, Isabelle, Soucaille, Philippe, Bottin, Hervé, Baffert, Carole, Fourmond, Vincent, Best, Robert B., Blumberger, Jochen, Léger, Christophe
Publicado no Nat Chem (2016)

Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational s...

Por Baffert, Sandrine, Cottu, Paul, Kirova, Youlia M, Mercier, Florence, Simondi, Cécile, Bachelot, Thomas, Le Rhun, Emilie, Levy, Christelle, Gutierrez, Maya, Madranges, Nicolas, Moldovan, Cristian, Coudert, Bruno, Spaëth, Dominique, Serin, Daniel, Cotté, François-Emery, Benjamin, Laure, Maillard, Cathie, Laulhere-Vigneau, Sabine, Durand-Zaleski, Isabelle
Publicado no BMC Health Serv Res (2013)

Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent

Por Andraos, Rita, Qian, Zhiyan, Bonenfant, Débora, Rubert, Joëlle, Vangrevelinghe, Eric, Scheufler, Clemens, Marque, Fanny, Régnier, Catherine H., De Pover, Alain, Ryckelynck, Hugues, Bhagwat, Neha, Koppikar, Priya, Goel, Aviva, Wyder, Lorenza, Tavares, Gisele, Baffert, Fabienne, Pissot-Soldermann, Carole, Manley, Paul W., Gaul, Christoph, Voshol, Hans, Levine, Ross L., Sellers, William R., Hofmann, Francesco, Radimerski, Thomas
Publicado no Cancer Discov (2012)

Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of...

Por Classe, J. M., Baffert, S., Sigal-Zafrani, B., Fall, M., Rousseau, C., Alran, S., Rouanet, P., Belichard, C., Mignotte, H., Ferron, G., Marchal, F., Giard, S., Tunon de Lara, C., Le Bouedec, G., Cuisenier, J., Werner, R., Raoust, I., Rodier, J.-F., Laki, F., Colombo, P.-E., Lasry, S., Faure, C., Charitansky, H., Olivier, J.-B., Chauvet, M.-P., Bussières, E., Gimbergues, P., Flipo, B., Houvenaeghel, G., Dravet, F., Livartowski, A.
Publicado em 2012

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

Por Weigert, Oliver, Lane, Andrew A., Bird, Liat, Kopp, Nadja, Chapuy, Bjoern, van Bodegom, Diederik, Toms, Angela V., Marubayashi, Sachie, Christie, Amanda L., McKeown, Michael, Paranal, Ronald M., Bradner, James E., Yoda, Akinori, Gaul, Christoph, Vangrevelinghe, Eric, Romanet, Vincent, Murakami, Masato, Tiedt, Ralph, Ebel, Nicolas, Evrot, Emeline, De Pover, Alain, Régnier, Catherine H., Erdmann, Dirk, Hofmann, Francesco, Eck, Michael J., Sallan, Stephen E., Levine, Ross L., Kung, Andrew L., Baffert, Fabienne, Radimerski, Thomas, Weinstock, David M.
Publicado em 2012

CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms

Por Meyer, Sara C., Keller, Matthew D., Chiu, Sophia, Koppikar, Priya, Guryanova, Olga A., Rapaport, Franck, Xu, Ke, Manova, Katia, Pankov, Dmitry, O’Reilly, Richard J., Kleppe, Maria, McKenney, Anna Sophia, Shih, Alan H., Shank, Kaitlyn, Ahn, Jihae, Papalexi, Eftymia, Spitzer, Barbara, Socci, Nick, Viale, Agnes, Mandon, Emeline, Ebel, Nicolas, Andraos, Rita, Rubert, Joëlle, Dammassa, Ernesta, Romanet, Vincent, Dölemeyer, Arno, Zender, Michael, Heinlein, Melanie, Rampal, Rajit, Weinberg, Rona Singer, Hoffman, Ron, Sellers, William R., Hofmann, Francesco, Murakami, Masato, Baffert, Fabienne, Gaul, Christoph, Radimerski, Thomas, Levine, Ross L.
Publicado no Cancer Cell (2015)

Activity of the type II JAK2 inhibitor CHZ868 in B-cell acute lymphoblastic leukemia

Por Wu, Shuo-Chieh, Li, Loretta S., Kopp, Nadja, Montero, Joan, Chapuy, Bjoern, Yoda, Akinori, Christie, Amanda L., Liu, Huiyun, Christodoulou, Alexandra, van Bodegom, Diederik, van der Zwet, Jordy, Layer, Jacob V., Tivey, Trevor, Lane, Andrew A., Ryan, Jeremy A., Ng, Samuel Y., DeAngelo, Daniel J., Stone, Richard M., Steensma, David, Wadleigh, Martha, Harris, Marian, Mandon, Emeline, Ebel, Nicolas, Andraos, Rita, Romanet, Vincent, Dölemeyer, Arno, Sterker, Dario, Zender, Michael, Rodig, Scott J., Murakami, Masato, Hofmann, Francesco, Kuo, Frank, Eck, Michael J., Silverman, Lewis B., Sallan, Stephen E., Letai, Anthony, Baffert, Fabienne, Vangrevelinghe, Eric, Radimerski, Thomas, Gaul, Christoph, Weinstock, David M.
Publicado no Cancer Cell (2015)